Global NGS-based RNA-seq Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global NGS-based RNA-seq market size was valued at US$ 1501.1 million in 2023. With growing demand in downstream market, the NGS-based RNA-seq is forecast to a readjusted size of US$ 3261.2 million by 2030 with a CAGR of 11.7% during review period.
The research report highlights the growth potential of the global NGS-based RNA-seq market. NGS-based RNA-seq are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of NGS-based RNA-seq. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the NGS-based RNA-seq market.
Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market.
The hospitals and clinics segment is expected to register the highest growth due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics.
Key Features:
The report on NGS-based RNA-seq market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the NGS-based RNA-seq market. It may include historical data, market segmentation by Type (e.g., High-Throughput Sequencing, Third-Generation Sequencing Technology), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the NGS-based RNA-seq market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the NGS-based RNA-seq market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the NGS-based RNA-seq industry. This include advancements in NGS-based RNA-seq technology, NGS-based RNA-seq new entrants, NGS-based RNA-seq new investment, and other innovations that are shaping the future of NGS-based RNA-seq.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the NGS-based RNA-seq market. It includes factors influencing customer ' purchasing decisions, preferences for NGS-based RNA-seq product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the NGS-based RNA-seq market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting NGS-based RNA-seq market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the NGS-based RNA-seq market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the NGS-based RNA-seq industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the NGS-based RNA-seq market.
Market Segmentation:
NGS-based RNA-seq market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global NGS-based RNA-seq market size was valued at US$ 1501.1 million in 2023. With growing demand in downstream market, the NGS-based RNA-seq is forecast to a readjusted size of US$ 3261.2 million by 2030 with a CAGR of 11.7% during review period.
The research report highlights the growth potential of the global NGS-based RNA-seq market. NGS-based RNA-seq are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of NGS-based RNA-seq. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the NGS-based RNA-seq market.
Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market.
The hospitals and clinics segment is expected to register the highest growth due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics.
Key Features:
The report on NGS-based RNA-seq market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the NGS-based RNA-seq market. It may include historical data, market segmentation by Type (e.g., High-Throughput Sequencing, Third-Generation Sequencing Technology), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the NGS-based RNA-seq market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the NGS-based RNA-seq market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the NGS-based RNA-seq industry. This include advancements in NGS-based RNA-seq technology, NGS-based RNA-seq new entrants, NGS-based RNA-seq new investment, and other innovations that are shaping the future of NGS-based RNA-seq.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the NGS-based RNA-seq market. It includes factors influencing customer ' purchasing decisions, preferences for NGS-based RNA-seq product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the NGS-based RNA-seq market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting NGS-based RNA-seq market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the NGS-based RNA-seq market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the NGS-based RNA-seq industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the NGS-based RNA-seq market.
Market Segmentation:
NGS-based RNA-seq market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- High-Throughput Sequencing
- Third-Generation Sequencing Technology
- Hospitals and Clinics
- Biopharma Companies
- Government Agencies
- Academic and Research Organizations
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Illumina
- Thermo Fisher Scientific
- Pacific Biosciences Of California
- Qaigen
- F. Hoffmann-La Roche
- Agilent Technologies
- Oxford Nanopore Technologies
- Perkinelmer
- Eurofins Scientific
- Gatc Biotech
- Macrogen
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global NGS-based RNA-seq Market Size 2019-2030
2.1.2 NGS-based RNA-seq Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 NGS-based RNA-seq Segment by Type
2.2.1 High-Throughput Sequencing
2.2.2 Third-Generation Sequencing Technology
2.3 NGS-based RNA-seq Market Size by Type
2.3.1 NGS-based RNA-seq Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global NGS-based RNA-seq Market Size Market Share by Type (2019-2024)
2.4 NGS-based RNA-seq Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Biopharma Companies
2.4.3 Government Agencies
2.4.4 Academic and Research Organizations
2.4.5 Other
2.5 NGS-based RNA-seq Market Size by Application
2.5.1 NGS-based RNA-seq Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global NGS-based RNA-seq Market Size Market Share by Application (2019-2024)
3 NGS-BASED RNA-SEQ MARKET SIZE BY PLAYER
3.1 NGS-based RNA-seq Market Size Market Share by Players
3.1.1 Global NGS-based RNA-seq Revenue by Players (2019-2024)
3.1.2 Global NGS-based RNA-seq Revenue Market Share by Players (2019-2024)
3.2 Global NGS-based RNA-seq Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NGS-BASED RNA-SEQ BY REGIONS
4.1 NGS-based RNA-seq Market Size by Regions (2019-2024)
4.2 Americas NGS-based RNA-seq Market Size Growth (2019-2024)
4.3 APAC NGS-based RNA-seq Market Size Growth (2019-2024)
4.4 Europe NGS-based RNA-seq Market Size Growth (2019-2024)
4.5 Middle East & Africa NGS-based RNA-seq Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas NGS-based RNA-seq Market Size by Country (2019-2024)
5.2 Americas NGS-based RNA-seq Market Size by Type (2019-2024)
5.3 Americas NGS-based RNA-seq Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NGS-based RNA-seq Market Size by Region (2019-2024)
6.2 APAC NGS-based RNA-seq Market Size by Type (2019-2024)
6.3 APAC NGS-based RNA-seq Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe NGS-based RNA-seq by Country (2019-2024)
7.2 Europe NGS-based RNA-seq Market Size by Type (2019-2024)
7.3 Europe NGS-based RNA-seq Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa NGS-based RNA-seq by Region (2019-2024)
8.2 Middle East & Africa NGS-based RNA-seq Market Size by Type (2019-2024)
8.3 Middle East & Africa NGS-based RNA-seq Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NGS-BASED RNA-SEQ MARKET FORECAST
10.1 Global NGS-based RNA-seq Forecast by Regions (2025-2030)
10.1.1 Global NGS-based RNA-seq Forecast by Regions (2025-2030)
10.1.2 Americas NGS-based RNA-seq Forecast
10.1.3 APAC NGS-based RNA-seq Forecast
10.1.4 Europe NGS-based RNA-seq Forecast
10.1.5 Middle East & Africa NGS-based RNA-seq Forecast
10.2 Americas NGS-based RNA-seq Forecast by Country (2025-2030)
10.2.1 United States NGS-based RNA-seq Market Forecast
10.2.2 Canada NGS-based RNA-seq Market Forecast
10.2.3 Mexico NGS-based RNA-seq Market Forecast
10.2.4 Brazil NGS-based RNA-seq Market Forecast
10.3 APAC NGS-based RNA-seq Forecast by Region (2025-2030)
10.3.1 China NGS-based RNA-seq Market Forecast
10.3.2 Japan NGS-based RNA-seq Market Forecast
10.3.3 Korea NGS-based RNA-seq Market Forecast
10.3.4 Southeast Asia NGS-based RNA-seq Market Forecast
10.3.5 India NGS-based RNA-seq Market Forecast
10.3.6 Australia NGS-based RNA-seq Market Forecast
10.4 Europe NGS-based RNA-seq Forecast by Country (2025-2030)
10.4.1 Germany NGS-based RNA-seq Market Forecast
10.4.2 France NGS-based RNA-seq Market Forecast
10.4.3 UK NGS-based RNA-seq Market Forecast
10.4.4 Italy NGS-based RNA-seq Market Forecast
10.4.5 Russia NGS-based RNA-seq Market Forecast
10.5 Middle East & Africa NGS-based RNA-seq Forecast by Region (2025-2030)
10.5.1 Egypt NGS-based RNA-seq Market Forecast
10.5.2 South Africa NGS-based RNA-seq Market Forecast
10.5.3 Israel NGS-based RNA-seq Market Forecast
10.5.4 Turkey NGS-based RNA-seq Market Forecast
10.5.5 GCC Countries NGS-based RNA-seq Market Forecast
10.6 Global NGS-based RNA-seq Forecast by Type (2025-2030)
10.7 Global NGS-based RNA-seq Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Illumina
11.1.1 Illumina Company Information
11.1.2 Illumina NGS-based RNA-seq Product Offered
11.1.3 Illumina NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Illumina Main Business Overview
11.1.5 Illumina Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific NGS-based RNA-seq Product Offered
11.2.3 Thermo Fisher Scientific NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 Pacific Biosciences Of California
11.3.1 Pacific Biosciences Of California Company Information
11.3.2 Pacific Biosciences Of California NGS-based RNA-seq Product Offered
11.3.3 Pacific Biosciences Of California NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Pacific Biosciences Of California Main Business Overview
11.3.5 Pacific Biosciences Of California Latest Developments
11.4 Qaigen
11.4.1 Qaigen Company Information
11.4.2 Qaigen NGS-based RNA-seq Product Offered
11.4.3 Qaigen NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Qaigen Main Business Overview
11.4.5 Qaigen Latest Developments
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Information
11.5.2 F. Hoffmann-La Roche NGS-based RNA-seq Product Offered
11.5.3 F. Hoffmann-La Roche NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 F. Hoffmann-La Roche Main Business Overview
11.5.5 F. Hoffmann-La Roche Latest Developments
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Information
11.6.2 Agilent Technologies NGS-based RNA-seq Product Offered
11.6.3 Agilent Technologies NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Agilent Technologies Main Business Overview
11.6.5 Agilent Technologies Latest Developments
11.7 Oxford Nanopore Technologies
11.7.1 Oxford Nanopore Technologies Company Information
11.7.2 Oxford Nanopore Technologies NGS-based RNA-seq Product Offered
11.7.3 Oxford Nanopore Technologies NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Oxford Nanopore Technologies Main Business Overview
11.7.5 Oxford Nanopore Technologies Latest Developments
11.8 Perkinelmer
11.8.1 Perkinelmer Company Information
11.8.2 Perkinelmer NGS-based RNA-seq Product Offered
11.8.3 Perkinelmer NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Perkinelmer Main Business Overview
11.8.5 Perkinelmer Latest Developments
11.9 Eurofins Scientific
11.9.1 Eurofins Scientific Company Information
11.9.2 Eurofins Scientific NGS-based RNA-seq Product Offered
11.9.3 Eurofins Scientific NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Eurofins Scientific Main Business Overview
11.9.5 Eurofins Scientific Latest Developments
11.10 Gatc Biotech
11.10.1 Gatc Biotech Company Information
11.10.2 Gatc Biotech NGS-based RNA-seq Product Offered
11.10.3 Gatc Biotech NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Gatc Biotech Main Business Overview
11.10.5 Gatc Biotech Latest Developments
11.11 Macrogen
11.11.1 Macrogen Company Information
11.11.2 Macrogen NGS-based RNA-seq Product Offered
11.11.3 Macrogen NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Macrogen Main Business Overview
11.11.5 Macrogen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global NGS-based RNA-seq Market Size 2019-2030
2.1.2 NGS-based RNA-seq Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 NGS-based RNA-seq Segment by Type
2.2.1 High-Throughput Sequencing
2.2.2 Third-Generation Sequencing Technology
2.3 NGS-based RNA-seq Market Size by Type
2.3.1 NGS-based RNA-seq Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global NGS-based RNA-seq Market Size Market Share by Type (2019-2024)
2.4 NGS-based RNA-seq Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Biopharma Companies
2.4.3 Government Agencies
2.4.4 Academic and Research Organizations
2.4.5 Other
2.5 NGS-based RNA-seq Market Size by Application
2.5.1 NGS-based RNA-seq Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global NGS-based RNA-seq Market Size Market Share by Application (2019-2024)
3 NGS-BASED RNA-SEQ MARKET SIZE BY PLAYER
3.1 NGS-based RNA-seq Market Size Market Share by Players
3.1.1 Global NGS-based RNA-seq Revenue by Players (2019-2024)
3.1.2 Global NGS-based RNA-seq Revenue Market Share by Players (2019-2024)
3.2 Global NGS-based RNA-seq Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NGS-BASED RNA-SEQ BY REGIONS
4.1 NGS-based RNA-seq Market Size by Regions (2019-2024)
4.2 Americas NGS-based RNA-seq Market Size Growth (2019-2024)
4.3 APAC NGS-based RNA-seq Market Size Growth (2019-2024)
4.4 Europe NGS-based RNA-seq Market Size Growth (2019-2024)
4.5 Middle East & Africa NGS-based RNA-seq Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas NGS-based RNA-seq Market Size by Country (2019-2024)
5.2 Americas NGS-based RNA-seq Market Size by Type (2019-2024)
5.3 Americas NGS-based RNA-seq Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC NGS-based RNA-seq Market Size by Region (2019-2024)
6.2 APAC NGS-based RNA-seq Market Size by Type (2019-2024)
6.3 APAC NGS-based RNA-seq Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe NGS-based RNA-seq by Country (2019-2024)
7.2 Europe NGS-based RNA-seq Market Size by Type (2019-2024)
7.3 Europe NGS-based RNA-seq Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa NGS-based RNA-seq by Region (2019-2024)
8.2 Middle East & Africa NGS-based RNA-seq Market Size by Type (2019-2024)
8.3 Middle East & Africa NGS-based RNA-seq Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NGS-BASED RNA-SEQ MARKET FORECAST
10.1 Global NGS-based RNA-seq Forecast by Regions (2025-2030)
10.1.1 Global NGS-based RNA-seq Forecast by Regions (2025-2030)
10.1.2 Americas NGS-based RNA-seq Forecast
10.1.3 APAC NGS-based RNA-seq Forecast
10.1.4 Europe NGS-based RNA-seq Forecast
10.1.5 Middle East & Africa NGS-based RNA-seq Forecast
10.2 Americas NGS-based RNA-seq Forecast by Country (2025-2030)
10.2.1 United States NGS-based RNA-seq Market Forecast
10.2.2 Canada NGS-based RNA-seq Market Forecast
10.2.3 Mexico NGS-based RNA-seq Market Forecast
10.2.4 Brazil NGS-based RNA-seq Market Forecast
10.3 APAC NGS-based RNA-seq Forecast by Region (2025-2030)
10.3.1 China NGS-based RNA-seq Market Forecast
10.3.2 Japan NGS-based RNA-seq Market Forecast
10.3.3 Korea NGS-based RNA-seq Market Forecast
10.3.4 Southeast Asia NGS-based RNA-seq Market Forecast
10.3.5 India NGS-based RNA-seq Market Forecast
10.3.6 Australia NGS-based RNA-seq Market Forecast
10.4 Europe NGS-based RNA-seq Forecast by Country (2025-2030)
10.4.1 Germany NGS-based RNA-seq Market Forecast
10.4.2 France NGS-based RNA-seq Market Forecast
10.4.3 UK NGS-based RNA-seq Market Forecast
10.4.4 Italy NGS-based RNA-seq Market Forecast
10.4.5 Russia NGS-based RNA-seq Market Forecast
10.5 Middle East & Africa NGS-based RNA-seq Forecast by Region (2025-2030)
10.5.1 Egypt NGS-based RNA-seq Market Forecast
10.5.2 South Africa NGS-based RNA-seq Market Forecast
10.5.3 Israel NGS-based RNA-seq Market Forecast
10.5.4 Turkey NGS-based RNA-seq Market Forecast
10.5.5 GCC Countries NGS-based RNA-seq Market Forecast
10.6 Global NGS-based RNA-seq Forecast by Type (2025-2030)
10.7 Global NGS-based RNA-seq Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Illumina
11.1.1 Illumina Company Information
11.1.2 Illumina NGS-based RNA-seq Product Offered
11.1.3 Illumina NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Illumina Main Business Overview
11.1.5 Illumina Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific NGS-based RNA-seq Product Offered
11.2.3 Thermo Fisher Scientific NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 Pacific Biosciences Of California
11.3.1 Pacific Biosciences Of California Company Information
11.3.2 Pacific Biosciences Of California NGS-based RNA-seq Product Offered
11.3.3 Pacific Biosciences Of California NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Pacific Biosciences Of California Main Business Overview
11.3.5 Pacific Biosciences Of California Latest Developments
11.4 Qaigen
11.4.1 Qaigen Company Information
11.4.2 Qaigen NGS-based RNA-seq Product Offered
11.4.3 Qaigen NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Qaigen Main Business Overview
11.4.5 Qaigen Latest Developments
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Information
11.5.2 F. Hoffmann-La Roche NGS-based RNA-seq Product Offered
11.5.3 F. Hoffmann-La Roche NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 F. Hoffmann-La Roche Main Business Overview
11.5.5 F. Hoffmann-La Roche Latest Developments
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Information
11.6.2 Agilent Technologies NGS-based RNA-seq Product Offered
11.6.3 Agilent Technologies NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Agilent Technologies Main Business Overview
11.6.5 Agilent Technologies Latest Developments
11.7 Oxford Nanopore Technologies
11.7.1 Oxford Nanopore Technologies Company Information
11.7.2 Oxford Nanopore Technologies NGS-based RNA-seq Product Offered
11.7.3 Oxford Nanopore Technologies NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Oxford Nanopore Technologies Main Business Overview
11.7.5 Oxford Nanopore Technologies Latest Developments
11.8 Perkinelmer
11.8.1 Perkinelmer Company Information
11.8.2 Perkinelmer NGS-based RNA-seq Product Offered
11.8.3 Perkinelmer NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Perkinelmer Main Business Overview
11.8.5 Perkinelmer Latest Developments
11.9 Eurofins Scientific
11.9.1 Eurofins Scientific Company Information
11.9.2 Eurofins Scientific NGS-based RNA-seq Product Offered
11.9.3 Eurofins Scientific NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Eurofins Scientific Main Business Overview
11.9.5 Eurofins Scientific Latest Developments
11.10 Gatc Biotech
11.10.1 Gatc Biotech Company Information
11.10.2 Gatc Biotech NGS-based RNA-seq Product Offered
11.10.3 Gatc Biotech NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Gatc Biotech Main Business Overview
11.10.5 Gatc Biotech Latest Developments
11.11 Macrogen
11.11.1 Macrogen Company Information
11.11.2 Macrogen NGS-based RNA-seq Product Offered
11.11.3 Macrogen NGS-based RNA-seq Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Macrogen Main Business Overview
11.11.5 Macrogen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. NGS-based RNA-seq Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of High-Throughput Sequencing
Table 3. Major Players of Third-Generation Sequencing Technology
Table 4. NGS-based RNA-seq Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global NGS-based RNA-seq Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global NGS-based RNA-seq Market Size Market Share by Type (2019-2024)
Table 7. NGS-based RNA-seq Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global NGS-based RNA-seq Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global NGS-based RNA-seq Market Size Market Share by Application (2019-2024)
Table 10. Global NGS-based RNA-seq Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global NGS-based RNA-seq Revenue Market Share by Player (2019-2024)
Table 12. NGS-based RNA-seq Key Players Head office and Products Offered
Table 13. NGS-based RNA-seq Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global NGS-based RNA-seq Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global NGS-based RNA-seq Market Size Market Share by Regions (2019-2024)
Table 18. Global NGS-based RNA-seq Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global NGS-based RNA-seq Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas NGS-based RNA-seq Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas NGS-based RNA-seq Market Size Market Share by Country (2019-2024)
Table 22. Americas NGS-based RNA-seq Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas NGS-based RNA-seq Market Size Market Share by Type (2019-2024)
Table 24. Americas NGS-based RNA-seq Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas NGS-based RNA-seq Market Size Market Share by Application (2019-2024)
Table 26. APAC NGS-based RNA-seq Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC NGS-based RNA-seq Market Size Market Share by Region (2019-2024)
Table 28. APAC NGS-based RNA-seq Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC NGS-based RNA-seq Market Size Market Share by Type (2019-2024)
Table 30. APAC NGS-based RNA-seq Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC NGS-based RNA-seq Market Size Market Share by Application (2019-2024)
Table 32. Europe NGS-based RNA-seq Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe NGS-based RNA-seq Market Size Market Share by Country (2019-2024)
Table 34. Europe NGS-based RNA-seq Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe NGS-based RNA-seq Market Size Market Share by Type (2019-2024)
Table 36. Europe NGS-based RNA-seq Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe NGS-based RNA-seq Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa NGS-based RNA-seq Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa NGS-based RNA-seq Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa NGS-based RNA-seq Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa NGS-based RNA-seq Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa NGS-based RNA-seq Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa NGS-based RNA-seq Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of NGS-based RNA-seq
Table 45. Key Market Challenges & Risks of NGS-based RNA-seq
Table 46. Key Industry Trends of NGS-based RNA-seq
Table 47. Global NGS-based RNA-seq Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global NGS-based RNA-seq Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global NGS-based RNA-seq Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global NGS-based RNA-seq Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Illumina Details, Company Type, NGS-based RNA-seq Area Served and Its Competitors
Table 52. Illumina NGS-based RNA-seq Product Offered
Table 53. Illumina NGS-based RNA-seq Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Illumina Main Business
Table 55. Illumina Latest Developments
Table 56. Thermo Fisher Scientific Details, Company Type, NGS-based RNA-seq Area Served and Its Competitors
Table 57. Thermo Fisher Scientific NGS-based RNA-seq Product Offered
Table 58. Thermo Fisher Scientific Main Business
Table 59. Thermo Fisher Scientific NGS-based RNA-seq Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Thermo Fisher Scientific Latest Developments
Table 61. Pacific Biosciences Of California Details, Company Type, NGS-based RNA-seq Area Served and Its Competitors
Table 62. Pacific Biosciences Of California NGS-based RNA-seq Product Offered
Table 63. Pacific Biosciences Of California Main Business
Table 64. Pacific Biosciences Of California NGS-based RNA-seq Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Pacific Biosciences Of California Latest Developments
Table 66. Qaigen Details, Company Type, NGS-based RNA-seq Area Served and Its Competitors
Table 67. Qaigen NGS-based RNA-seq Product Offered
Table 68. Qaigen Main Business
Table 69. Qaigen NGS-based RNA-seq Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Qaigen Latest Developments
Table 71. F. Hoffmann-La Roche Details, Company Type, NGS-based RNA-seq Area Served and Its Competitors
Table 72. F. Hoffmann-La Roche NGS-based RNA-seq Product Offered
Table 73. F. Hoffmann-La Roche Main Business
Table 74. F. Hoffmann-La Roche NGS-based RNA-seq Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. F. Hoffmann-La Roche Latest Developments
Table 76. Agilent Technologies Details, Company Type, NGS-based RNA-seq Area Served and Its Competitors
Table 77. Agilent Technologies NGS-based RNA-seq Product Offered
Table 78. Agilent Technologies Main Business
Table 79. Agilent Technologies NGS-based RNA-seq Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Agilent Technologies Latest Developments
Table 81. Oxford Nanopore Technologies Details, Company Type, NGS-based RNA-seq Area Served and Its Competitors
Table 82. Oxford Nanopore Technologies NGS-based RNA-seq Product Offered
Table 83. Oxford Nanopore Technologies Main Business
Table 84. Oxford Nanopore Technologies NGS-based RNA-seq Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Oxford Nanopore Technologies Latest Developments
Table 86. Perkinelmer Details, Company Type, NGS-based RNA-seq Area Served and Its Competitors
Table 87. Perkinelmer NGS-based RNA-seq Product Offered
Table 88. Perkinelmer Main Business
Table 89. Perkinelmer NGS-based RNA-seq Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Perkinelmer Latest Developments
Table 91. Eurofins Scientific Details, Company Type, NGS-based RNA-seq Area Served and Its Competitors
Table 92. Eurofins Scientific NGS-based RNA-seq Product Offered
Table 93. Eurofins Scientific Main Business
Table 94. Eurofins Scientific NGS-based RNA-seq Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Eurofins Scientific Latest Developments
Table 96. Gatc Biotech Details, Company Type, NGS-based RNA-seq Area Served and Its Competitors
Table 97. Gatc Biotech NGS-based RNA-seq Product Offered
Table 98. Gatc Biotech Main Business
Table 99. Gatc Biotech NGS-based RNA-seq Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Gatc Biotech Latest Developments
Table 101. Macrogen Details, Company Type, NGS-based RNA-seq Area Served and Its Competitors
Table 102. Macrogen NGS-based RNA-seq Product Offered
Table 103. Macrogen NGS-based RNA-seq Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Macrogen Main Business
Table 105. Macrogen Latest Developments
Table 1. NGS-based RNA-seq Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of High-Throughput Sequencing
Table 3. Major Players of Third-Generation Sequencing Technology
Table 4. NGS-based RNA-seq Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global NGS-based RNA-seq Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global NGS-based RNA-seq Market Size Market Share by Type (2019-2024)
Table 7. NGS-based RNA-seq Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global NGS-based RNA-seq Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global NGS-based RNA-seq Market Size Market Share by Application (2019-2024)
Table 10. Global NGS-based RNA-seq Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global NGS-based RNA-seq Revenue Market Share by Player (2019-2024)
Table 12. NGS-based RNA-seq Key Players Head office and Products Offered
Table 13. NGS-based RNA-seq Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global NGS-based RNA-seq Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global NGS-based RNA-seq Market Size Market Share by Regions (2019-2024)
Table 18. Global NGS-based RNA-seq Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global NGS-based RNA-seq Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas NGS-based RNA-seq Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas NGS-based RNA-seq Market Size Market Share by Country (2019-2024)
Table 22. Americas NGS-based RNA-seq Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas NGS-based RNA-seq Market Size Market Share by Type (2019-2024)
Table 24. Americas NGS-based RNA-seq Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas NGS-based RNA-seq Market Size Market Share by Application (2019-2024)
Table 26. APAC NGS-based RNA-seq Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC NGS-based RNA-seq Market Size Market Share by Region (2019-2024)
Table 28. APAC NGS-based RNA-seq Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC NGS-based RNA-seq Market Size Market Share by Type (2019-2024)
Table 30. APAC NGS-based RNA-seq Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC NGS-based RNA-seq Market Size Market Share by Application (2019-2024)
Table 32. Europe NGS-based RNA-seq Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe NGS-based RNA-seq Market Size Market Share by Country (2019-2024)
Table 34. Europe NGS-based RNA-seq Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe NGS-based RNA-seq Market Size Market Share by Type (2019-2024)
Table 36. Europe NGS-based RNA-seq Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe NGS-based RNA-seq Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa NGS-based RNA-seq Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa NGS-based RNA-seq Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa NGS-based RNA-seq Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa NGS-based RNA-seq Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa NGS-based RNA-seq Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa NGS-based RNA-seq Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of NGS-based RNA-seq
Table 45. Key Market Challenges & Risks of NGS-based RNA-seq
Table 46. Key Industry Trends of NGS-based RNA-seq
Table 47. Global NGS-based RNA-seq Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global NGS-based RNA-seq Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global NGS-based RNA-seq Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global NGS-based RNA-seq Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Illumina Details, Company Type, NGS-based RNA-seq Area Served and Its Competitors
Table 52. Illumina NGS-based RNA-seq Product Offered
Table 53. Illumina NGS-based RNA-seq Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Illumina Main Business
Table 55. Illumina Latest Developments
Table 56. Thermo Fisher Scientific Details, Company Type, NGS-based RNA-seq Area Served and Its Competitors
Table 57. Thermo Fisher Scientific NGS-based RNA-seq Product Offered
Table 58. Thermo Fisher Scientific Main Business
Table 59. Thermo Fisher Scientific NGS-based RNA-seq Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Thermo Fisher Scientific Latest Developments
Table 61. Pacific Biosciences Of California Details, Company Type, NGS-based RNA-seq Area Served and Its Competitors
Table 62. Pacific Biosciences Of California NGS-based RNA-seq Product Offered
Table 63. Pacific Biosciences Of California Main Business
Table 64. Pacific Biosciences Of California NGS-based RNA-seq Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Pacific Biosciences Of California Latest Developments
Table 66. Qaigen Details, Company Type, NGS-based RNA-seq Area Served and Its Competitors
Table 67. Qaigen NGS-based RNA-seq Product Offered
Table 68. Qaigen Main Business
Table 69. Qaigen NGS-based RNA-seq Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Qaigen Latest Developments
Table 71. F. Hoffmann-La Roche Details, Company Type, NGS-based RNA-seq Area Served and Its Competitors
Table 72. F. Hoffmann-La Roche NGS-based RNA-seq Product Offered
Table 73. F. Hoffmann-La Roche Main Business
Table 74. F. Hoffmann-La Roche NGS-based RNA-seq Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. F. Hoffmann-La Roche Latest Developments
Table 76. Agilent Technologies Details, Company Type, NGS-based RNA-seq Area Served and Its Competitors
Table 77. Agilent Technologies NGS-based RNA-seq Product Offered
Table 78. Agilent Technologies Main Business
Table 79. Agilent Technologies NGS-based RNA-seq Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Agilent Technologies Latest Developments
Table 81. Oxford Nanopore Technologies Details, Company Type, NGS-based RNA-seq Area Served and Its Competitors
Table 82. Oxford Nanopore Technologies NGS-based RNA-seq Product Offered
Table 83. Oxford Nanopore Technologies Main Business
Table 84. Oxford Nanopore Technologies NGS-based RNA-seq Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Oxford Nanopore Technologies Latest Developments
Table 86. Perkinelmer Details, Company Type, NGS-based RNA-seq Area Served and Its Competitors
Table 87. Perkinelmer NGS-based RNA-seq Product Offered
Table 88. Perkinelmer Main Business
Table 89. Perkinelmer NGS-based RNA-seq Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Perkinelmer Latest Developments
Table 91. Eurofins Scientific Details, Company Type, NGS-based RNA-seq Area Served and Its Competitors
Table 92. Eurofins Scientific NGS-based RNA-seq Product Offered
Table 93. Eurofins Scientific Main Business
Table 94. Eurofins Scientific NGS-based RNA-seq Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Eurofins Scientific Latest Developments
Table 96. Gatc Biotech Details, Company Type, NGS-based RNA-seq Area Served and Its Competitors
Table 97. Gatc Biotech NGS-based RNA-seq Product Offered
Table 98. Gatc Biotech Main Business
Table 99. Gatc Biotech NGS-based RNA-seq Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Gatc Biotech Latest Developments
Table 101. Macrogen Details, Company Type, NGS-based RNA-seq Area Served and Its Competitors
Table 102. Macrogen NGS-based RNA-seq Product Offered
Table 103. Macrogen NGS-based RNA-seq Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Macrogen Main Business
Table 105. Macrogen Latest Developments
LIST OF FIGURES
Figure 1. NGS-based RNA-seq Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global NGS-based RNA-seq Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. NGS-based RNA-seq Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. NGS-based RNA-seq Sales Market Share by Country/Region (2023)
Figure 8. NGS-based RNA-seq Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global NGS-based RNA-seq Market Size Market Share by Type in 2023
Figure 10. NGS-based RNA-seq in Hospitals and Clinics
Figure 11. Global NGS-based RNA-seq Market: Hospitals and Clinics (2019-2024) & ($ Millions)
Figure 12. NGS-based RNA-seq in Biopharma Companies
Figure 13. Global NGS-based RNA-seq Market: Biopharma Companies (2019-2024) & ($ Millions)
Figure 14. NGS-based RNA-seq in Government Agencies
Figure 15. Global NGS-based RNA-seq Market: Government Agencies (2019-2024) & ($ Millions)
Figure 16. NGS-based RNA-seq in Academic and Research Organizations
Figure 17. Global NGS-based RNA-seq Market: Academic and Research Organizations (2019-2024) & ($ Millions)
Figure 18. NGS-based RNA-seq in Other
Figure 19. Global NGS-based RNA-seq Market: Other (2019-2024) & ($ Millions)
Figure 20. Global NGS-based RNA-seq Market Size Market Share by Application in 2023
Figure 21. Global NGS-based RNA-seq Revenue Market Share by Player in 2023
Figure 22. Global NGS-based RNA-seq Market Size Market Share by Regions (2019-2024)
Figure 23. Americas NGS-based RNA-seq Market Size 2019-2024 ($ Millions)
Figure 24. APAC NGS-based RNA-seq Market Size 2019-2024 ($ Millions)
Figure 25. Europe NGS-based RNA-seq Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa NGS-based RNA-seq Market Size 2019-2024 ($ Millions)
Figure 27. Americas NGS-based RNA-seq Value Market Share by Country in 2023
Figure 28. United States NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC NGS-based RNA-seq Market Size Market Share by Region in 2023
Figure 33. APAC NGS-based RNA-seq Market Size Market Share by Type in 2023
Figure 34. APAC NGS-based RNA-seq Market Size Market Share by Application in 2023
Figure 35. China NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 39. India NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe NGS-based RNA-seq Market Size Market Share by Country in 2023
Figure 42. Europe NGS-based RNA-seq Market Size Market Share by Type (2019-2024)
Figure 43. Europe NGS-based RNA-seq Market Size Market Share by Application (2019-2024)
Figure 44. Germany NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 45. France NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa NGS-based RNA-seq Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa NGS-based RNA-seq Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa NGS-based RNA-seq Market Size Market Share by Application (2019-2024)
Figure 52. Egypt NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 58. APAC NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 59. Europe NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 61. United States NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 62. Canada NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 63. Mexico NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 64. Brazil NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 65. China NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 66. Japan NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 67. Korea NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 69. India NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 70. Australia NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 71. Germany NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 72. France NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 73. UK NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 74. Italy NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 75. Russia NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 76. Spain NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 77. Egypt NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 78. South Africa NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 79. Israel NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 80. Turkey NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 82. Global NGS-based RNA-seq Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global NGS-based RNA-seq Market Size Market Share Forecast by Application (2025-2030)
Figure 1. NGS-based RNA-seq Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global NGS-based RNA-seq Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. NGS-based RNA-seq Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. NGS-based RNA-seq Sales Market Share by Country/Region (2023)
Figure 8. NGS-based RNA-seq Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global NGS-based RNA-seq Market Size Market Share by Type in 2023
Figure 10. NGS-based RNA-seq in Hospitals and Clinics
Figure 11. Global NGS-based RNA-seq Market: Hospitals and Clinics (2019-2024) & ($ Millions)
Figure 12. NGS-based RNA-seq in Biopharma Companies
Figure 13. Global NGS-based RNA-seq Market: Biopharma Companies (2019-2024) & ($ Millions)
Figure 14. NGS-based RNA-seq in Government Agencies
Figure 15. Global NGS-based RNA-seq Market: Government Agencies (2019-2024) & ($ Millions)
Figure 16. NGS-based RNA-seq in Academic and Research Organizations
Figure 17. Global NGS-based RNA-seq Market: Academic and Research Organizations (2019-2024) & ($ Millions)
Figure 18. NGS-based RNA-seq in Other
Figure 19. Global NGS-based RNA-seq Market: Other (2019-2024) & ($ Millions)
Figure 20. Global NGS-based RNA-seq Market Size Market Share by Application in 2023
Figure 21. Global NGS-based RNA-seq Revenue Market Share by Player in 2023
Figure 22. Global NGS-based RNA-seq Market Size Market Share by Regions (2019-2024)
Figure 23. Americas NGS-based RNA-seq Market Size 2019-2024 ($ Millions)
Figure 24. APAC NGS-based RNA-seq Market Size 2019-2024 ($ Millions)
Figure 25. Europe NGS-based RNA-seq Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa NGS-based RNA-seq Market Size 2019-2024 ($ Millions)
Figure 27. Americas NGS-based RNA-seq Value Market Share by Country in 2023
Figure 28. United States NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC NGS-based RNA-seq Market Size Market Share by Region in 2023
Figure 33. APAC NGS-based RNA-seq Market Size Market Share by Type in 2023
Figure 34. APAC NGS-based RNA-seq Market Size Market Share by Application in 2023
Figure 35. China NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 39. India NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe NGS-based RNA-seq Market Size Market Share by Country in 2023
Figure 42. Europe NGS-based RNA-seq Market Size Market Share by Type (2019-2024)
Figure 43. Europe NGS-based RNA-seq Market Size Market Share by Application (2019-2024)
Figure 44. Germany NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 45. France NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa NGS-based RNA-seq Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa NGS-based RNA-seq Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa NGS-based RNA-seq Market Size Market Share by Application (2019-2024)
Figure 52. Egypt NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country NGS-based RNA-seq Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 58. APAC NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 59. Europe NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 61. United States NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 62. Canada NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 63. Mexico NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 64. Brazil NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 65. China NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 66. Japan NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 67. Korea NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 69. India NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 70. Australia NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 71. Germany NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 72. France NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 73. UK NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 74. Italy NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 75. Russia NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 76. Spain NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 77. Egypt NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 78. South Africa NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 79. Israel NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 80. Turkey NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries NGS-based RNA-seq Market Size 2025-2030 ($ Millions)
Figure 82. Global NGS-based RNA-seq Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global NGS-based RNA-seq Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Anaphylaxis Epinephrine Market Growth 2023-2029
US$ 3,660.00
March 2023
106 pages
Global Latent Tuberculosis Infection (LTBI) Testing Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
January 2025
84 pages
Global Medical Surgical Face Masks Market Growth 2023-2029
US$ 3,660.00
March 2023
118 pages
Global Radiotherapy Patient Positioning Devices Market Growth 2025-2031
US$ 3,660.00
August 2025
136 pages
Global Hybridization Tube Racks Market Growth 2024-2030
US$ 3,660.00
December 2024
86 pages
